Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Acta médica Grupo Ángeles
Print version ISSN 1870-7203
Abstract
LUGO BAUTISTA, Karla Sharon; MEDINA RODRIGUEZ, José Carlos; RODRIGUEZ WEBER, Federico Leopoldo and DIAZ GREENE, Enrique Juan. Depressive symptoms as predictors of treatment adherence in patients with type 2 diabetes: a cross-sectional study. Acta méd. Grupo Ángeles [online]. 2023, vol.21, n.1, pp.28-31. Epub June 09, 2023. ISSN 1870-7203. https://doi.org/10.35366/109017.
Introduction:
type 2 diabetes (T2D) is a condition with a high disease burden and is frequently accompanied by depressive symptoms, which could affect treatment adherence.
Objective:
a cross-sectional study was done to measure the impact of depressive symptoms on adherence to treatment of people with T2D.
Material and methods:
sociodemographic data were collected; the Hamilton depression scale (HADS) was used to measure depressive symptoms, and the Morisky medication adherence scale (MMAS) to assess adherence.
Results:
correlations were found between the male gender and the number of antidiabetic medications, physical activity, and several medications, and HADS score and low adherence. A significant regression was found between the HADS and MMAS scores.
Conclusions:
depressive symptoms were predictors of adherence in patients with T2D, and associations were found between sociodemographic and clinical variables.
Keywords : depression; diabetes mellitus; medication adherence.
